WFU

2015年9月27日 星期日

Bone Remodeling at 2015: from Repair, Healing, Adaptation, to Regeneration

Title: Bone Remodeling at 2015: from Repair, Healing, Adaptation, to Regeneration



Andy Y-T. Teng;



Center for Osteoimmunology and Biotechnology Research (COBR), College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan



Abstract:



It is now clear that bone is dynamically modulated by its multi-cellular unit (BMU), interconnected through the hierarchy of trabecular system leveled to subcellular-molecular laculo-canalicular structures, made of live osteoblasts (OB), pre-OB, osteocytes & bone-lining cells, osteoclasts (OC) & OC precursors, and the matrix-mesenchyme as well; each of which contribute to the activities of skeletal-bone remodeling compartment (BRC).  In human’s skeleton, the basic modeling and remodeling processes are physiologically orchestrated by an arrayed constellation of intrinsic vs. extrinsic regulatory signals (e.g., RANKL-RANK/OPG, JAK-STATS, etc.) via specific chemokines, cytokines (i.e., TGF-b & IL-17/23, etc.), peptides and hormones (i.e., PTH, estrogens), physical activities (i.e., dynamic loading or exercises) in comparison to physiologic vs. pathogenic constrains, that fine-tune the balanced outcomes from any biological events yielding to bone repair, adaptation, united healing, or regeneration in BMU.  Upon triggering mechano-loading or stress-related damages, unique signals are molecule-sensed by the osteocyte network, followed by recruitment of OC precursors, signifying the resorbing matrix products in the BRC to modulate such cycling events towards activated (re)-modeling machinery resulting in a net gain or loss of the bone in-volumes (from bio-synthesis, repair, adaptive changes to destruction or regeneration) throughout the BMU in its life time.
This oral presentation will feature a summative perspective of some critical clinical entities, such as the MRONJ, wound healing in bone & osteomyelitis, peri-implantitis, and mesenchymal stem cells for bone regeneration at the osteo-immune interface regarding the key osteotropic cytokines/factors in relation to skeletal (re)-modeling involved in the osteoporotic conditions and the cancer-to-bone metastasis. Moreover, highlight on the links between RANKL-RANK/OPG triads and molecular engineering for potent bone regeneration will also be briefly elucidated for future perspective.